Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Peace

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cardiology|February 8, 2022
Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficultCharles Knoery, Katie A McEwan, Matthew Manktelow, et al.
Journal of Electrocardiology|August 21, 2018
Automation bias in medicine: The influence of automated diagnoses on interpreter accuracy and uncertainty when reading electrocardiogramsRaymond R Bond, Tomas Novotny, Irena Andrsova, et al.
European Journal of Heart Failure|November 3, 2011
Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failureNelson Gomez, Karim Touihri, Veerle Matheeussen, et al.
Open Heart|March 31, 2026
Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarctionJack Laffan, Huixuan Gao, Andrew Street, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Effective radiation dose, time, and contrast medium to measure fractional flow reserveArgyrios Ntalianis, Catalina Trana, Olivier Muller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2025
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trialAlexander M Griffioen, Robert-Jan M van Geuns, Margaret B McEntegart, et al.
JACC. Cardiovascular Interventions|November 27, 2024
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding RiskMarco Roffi, Antonio Landi, Dik Heg, et al.
JACC. Basic to Translational Science|June 25, 2025
NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E-Deficient MiceLucie Delfos, Marie A C Depuydt, Melody Chemaly, et al.
Biomolecules|September 28, 2024
Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 PatientsThomas McLarnon, Darren McDaid, Seodhna M Lynch, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cardiology|February 8, 2022
Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficultCharles Knoery, Katie A McEwan, Matthew Manktelow, et al.
Journal of Electrocardiology|August 21, 2018
Automation bias in medicine: The influence of automated diagnoses on interpreter accuracy and uncertainty when reading electrocardiogramsRaymond R Bond, Tomas Novotny, Irena Andrsova, et al.
European Journal of Heart Failure|November 3, 2011
Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failureNelson Gomez, Karim Touihri, Veerle Matheeussen, et al.
Open Heart|March 31, 2026
Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarctionJack Laffan, Huixuan Gao, Andrew Street, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Effective radiation dose, time, and contrast medium to measure fractional flow reserveArgyrios Ntalianis, Catalina Trana, Olivier Muller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2025
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trialAlexander M Griffioen, Robert-Jan M van Geuns, Margaret B McEntegart, et al.
JACC. Cardiovascular Interventions|November 27, 2024
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding RiskMarco Roffi, Antonio Landi, Dik Heg, et al.
JACC. Basic to Translational Science|June 25, 2025
NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E-Deficient MiceLucie Delfos, Marie A C Depuydt, Melody Chemaly, et al.
Biomolecules|September 28, 2024
Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 PatientsThomas McLarnon, Darren McDaid, Seodhna M Lynch, et al.
Pageof 6